Tong Ren Tang Technologies Co. Ltd. (TGRNF)
USD 0.69
(0.0%)
USD 0.69
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.62 Billion CNY | 2.03% |
| 2022 | 1.59 Billion CNY | -2.97% |
| 2021 | 1.64 Billion CNY | -2.57% |
| 2020 | 1.68 Billion CNY | 15.26% |
| 2019 | 1.46 Billion CNY | 31.69% |
| 2018 | 1.11 Billion CNY | -1.23% |
| 2017 | 1.12 Billion CNY | -0.29% |
| 2016 | 1.12 Billion CNY | 520.18% |
| 2015 | 181.97 Million CNY | 81.97% |
| 2014 | 100 Million CNY | -48.54% |
| 2013 | 194.31 Million CNY | 51.0% |
| 2012 | 128.67 Million CNY | 2.94% |
| 2011 | 125 Million CNY | 733.33% |
| 2010 | 15 Million CNY | 0.0% |
| 2009 | 15 Million CNY | 0.0% |
| 2008 | 15 Million CNY | 0.0% |
| 2007 | 15 Million CNY | -82.35% |
| 2006 | 85 Million CNY | 0.0% |
| 2005 | 85 Million CNY | 13.33% |
| 2004 | 75 Million CNY | 400.0% |
| 2003 | 15 Million CNY | 0.0% |
| 2002 | 15 Million CNY | -50.0% |
| 2001 | 30 Million CNY | -33.92% |
| 2000 | 45.4 Million CNY | 0.0% |
| 1999 | 45.4 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.23 Billion CNY | 37.44% |
| 2024 Q2 | 2.23 Billion CNY | 0.0% |
| 2023 Q2 | 1.65 Billion CNY | 4.6% |
| 2023 FY | 1.62 Billion CNY | 2.03% |
| 2023 Q1 | 1.58 Billion CNY | -0.73% |
| 2023 Q4 | 1.62 Billion CNY | 4.81% |
| 2023 Q3 | 1.55 Billion CNY | -6.25% |
| 2022 Q1 | 1.57 Billion CNY | -4.09% |
| 2022 Q2 | 1.63 Billion CNY | 3.94% |
| 2022 Q3 | 1.54 Billion CNY | -5.59% |
| 2022 Q4 | 1.59 Billion CNY | 3.1% |
| 2022 FY | 1.59 Billion CNY | -2.97% |
| 2021 Q2 | 2.5 Billion CNY | 2.64% |
| 2021 Q4 | 1.64 Billion CNY | 4.04% |
| 2021 Q1 | 2.43 Billion CNY | 44.62% |
| 2021 FY | 1.64 Billion CNY | -2.57% |
| 2021 Q3 | 1.57 Billion CNY | -36.91% |
| 2020 FY | 1.68 Billion CNY | 15.26% |
| 2020 Q1 | 1.61 Billion CNY | 10.07% |
| 2020 Q2 | 1.64 Billion CNY | 2.33% |
| 2020 Q3 | 1.63 Billion CNY | -0.87% |
| 2020 Q4 | 1.68 Billion CNY | 3.22% |
| 2019 Q3 | 1.42 Billion CNY | 30.56% |
| 2019 Q1 | 1.04 Billion CNY | -5.92% |
| 2019 Q2 | 1.09 Billion CNY | 4.27% |
| 2019 Q4 | 1.46 Billion CNY | 2.83% |
| 2019 FY | 1.46 Billion CNY | 31.69% |
| 2018 Q1 | 1.08 Billion CNY | -3.69% |
| 2018 Q4 | 1.11 Billion CNY | 0.0% |
| 2018 FY | 1.11 Billion CNY | -1.23% |
| 2018 Q2 | 1.08 Billion CNY | 0.0% |
| 2018 Q3 | 1.11 Billion CNY | 2.56% |
| 2017 Q2 | 1.12 Billion CNY | 0.0% |
| 2017 Q4 | 1.12 Billion CNY | 0.0% |
| 2017 FY | 1.12 Billion CNY | -0.29% |
| 2017 Q3 | 1.12 Billion CNY | 0.02% |
| 2017 Q1 | 1.12 Billion CNY | -0.31% |
| 2016 Q1 | 204.49 Million CNY | 12.38% |
| 2016 Q2 | 204.49 Million CNY | 0.0% |
| 2016 Q3 | 1.12 Billion CNY | 451.88% |
| 2016 Q4 | 1.12 Billion CNY | 0.0% |
| 2016 FY | 1.12 Billion CNY | 520.18% |
| 2015 FY | 181.97 Million CNY | 81.97% |
| 2015 Q1 | 165.4 Million CNY | 65.41% |
| 2015 Q2 | 165.4 Million CNY | 0.0% |
| 2015 Q3 | 181.97 Million CNY | 10.01% |
| 2015 Q4 | 181.97 Million CNY | 0.0% |
| 2014 Q3 | 100 Million CNY | -33.33% |
| 2014 Q1 | 150 Million CNY | -22.8% |
| 2014 Q4 | 100 Million CNY | 0.0% |
| 2014 FY | 100 Million CNY | -48.54% |
| 2014 Q2 | 150 Million CNY | 0.0% |
| 2013 Q4 | 194.31 Million CNY | 0.0% |
| 2013 FY | 194.31 Million CNY | 51.0% |
| 2013 Q3 | 194.31 Million CNY | 17.89% |
| 2013 Q2 | 164.83 Million CNY | 0.0% |
| 2013 Q1 | 164.83 Million CNY | 28.09% |
| 2012 FY | 128.67 Million CNY | 2.94% |
| 2012 Q2 | 125 Million CNY | 0.0% |
| 2012 Q4 | 128.67 Million CNY | 0.0% |
| 2011 Q4 | 125 Million CNY | 0.0% |
| 2011 FY | 125 Million CNY | 733.33% |
| 2011 Q2 | 45 Million CNY | 0.0% |
| 2010 Q2 | 15 Million CNY | 0.0% |
| 2010 Q4 | 15 Million CNY | 0.0% |
| 2010 FY | 15 Million CNY | 0.0% |
| 2009 Q4 | 15 Million CNY | 0.0% |
| 2009 FY | 15 Million CNY | 0.0% |
| 2008 FY | 15 Million CNY | 0.0% |
| 2007 FY | 15 Million CNY | -82.35% |
| 2006 FY | 85 Million CNY | 0.0% |
| 2005 FY | 85 Million CNY | 13.33% |
| 2004 FY | 75 Million CNY | 400.0% |
| 2003 FY | 15 Million CNY | 0.0% |
| 2002 FY | 15 Million CNY | -50.0% |
| 2001 FY | 30 Million CNY | -33.92% |
| 2000 FY | 45.4 Million CNY | 0.0% |
| 1999 FY | 45.4 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AstraZeneca PLC | 28.58 Billion USD | 94.307% |
| Bristol-Myers Squibb Company PFD CONV 2 | 41.46 Billion USD | 96.076% |
| CSPC Pharmaceutical Group Limited | 99.64 Million USD | -1532.995% |
| Clarus Therapeutics Holdings, Inc. | 42.26 Million USD | -3749.663% |
| Novartis AG | 26.34 Billion USD | 93.824% |
| PT Kalbe Farma Tbk. | 40.4 Million USD | -3927.183% |